Prognostic molecular signature of sarcomas, and uses thereof
US9708666B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 21, 2010 |
| Grant date | Jul 18, 2017 |
| Priority date | — |
| Expiry date | Oct 29, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are methods and compositions that can be used for diagnosis and treatment of soft tissue sarcoma cancer phenotypes and soft tissue sarcoma cancer-associated diseases. Also described herein are methods that can be used to identify modulators of soft tissue sarcoma cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.